Polymorphisms of the Endothelin-1 Gene Associate with Hypertension in Patients with Rheumatoid Arthritis

REFERENCES

• Automated nucleic acid exraction-QuickGene-810. 2007a, Available online at http://www.autogen.com/Products/QuickGene810.htm
   Google Scholar
• Arinami T., Ishikawa M., Inoue A., Yanagisawa M., Masaki T., Yoshida M. C., et al. Chromosomal assignments of the human endothelin family genes: the endothelin-1 gene (EDN1) to 6p23–p24, the endothelin-2 gene (EDN2) to 1p34, and the endothelin-3 gene (EDN3) to 20q13.2-q13.3. American Journal of Human Genetics 1991; 48: 990–996
   PubMed Web of Science ®Google Scholar
• Arnett F. C., Edworthy S. M., Bloch D. A., McShane D. J., Fries J. F., Cooper N. S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis and Rheumatism 1988; 31: 315–324
   PubMed Web of Science ®Google Scholar
• Asai T., Ohkubo T., Katsuya T., Higaki J., Fu Y., Fukuda M., et al. Endothelin-1 gene variant associates with blood pressure in obese Japanese subjects: the Ohasama Study. Hypertension 2001; 38: 1321–1324
   PubMed Web of Science ®Google Scholar
• Assous N., Touze E., Meune C., Kahan A., Allanore Y. Cardiovascular disease in rheumatoid arthritis: single-center hospital-based cohort study in France. Joint, Bone, Spine 2007; 74: 66–72
   PubMed Web of Science ®Google Scholar
• Cardillo C., Campia U., Kilcoyne C. M., Bryant M. B., Panza J. A. Improved endothelium-dependent vasodilation after blockade of endothelin receptors in patients with essential hypertension. Circulation 2002; 105: 452–456
   PubMed Web of Science ®Google Scholar
• Davenport A. P., Ashby M. J., Easton P., Ella S., Bedford J., Dickerson C., et al. A sensitive radioimmunoassay measuring endothelin-like immunoreactivity in human plasma: comparison of levels in patients with essential hypertension and normotensive control subjects. Clinical Science 1990; 78: 261–264
   PubMed Web of Science ®Google Scholar
• Davey S. G., Ebrahim S. ‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease?. International Journal of Epidemiology 2003; 32: 1–22
   PubMed Web of Science ®Google Scholar
• Desideri G., Ferri C., Bellini C., De Mattia G., Santucci A. Effects of ACE inhibition on spontaneous and insulin-stimulated endothelin-1 secretion: In vitro and in vivo studies. Diabetes 1997; 46: 81–86
   PubMed Web of Science ®Google Scholar
• Dessein P. H., Tobias M., Veller M. G. Metabolic syndrome and subclinical atherosclerosis in rheumatoid arthritis. Journal of Rheumatology 2006; 33: 2425–2432
   PubMed Web of Science ®Google Scholar
• Devlin B., Risch N. A comparison of linkage disequilibrium measures for fine-scale mapping. Genomics 1995; 29: 311–322
   PubMed Web of Science ®Google Scholar
• Ehrenreich H., Anderson R. W., Fox C. H., Rieckmann P., Hoffman G. S., Travis W. D., et al. Endothelins, peptides with potent vasoactive properties, are produced by human macrophages. Journal of Experimental Medicine 1990; 172: 1741–1748
   PubMed Web of Science ®Google Scholar
• Elijovich F., Laffer C. L. Participation of renal and circulating endothelin in salt-sensitive essential hypertension. Journal of Human Hypertension 2002; 16: 459–467
   PubMed Web of Science ®Google Scholar
• Elijovich F., Laffer C. L., Amador E., Gavras H., Bresnahan M. R., Schiffrin E. L. Regulation of plasma endothelin by salt in salt-sensitive hypertension. Circulation 2001; 103: 263–268
   PubMed Web of Science ®Google Scholar
• Ergul S., Parish D. C., Puett D., Ergul A. Racial differences in plasma endothelin-1 concentrations in individuals with essential hypertension. Hypertension 1996; 28: 652–655
   PubMed Web of Science ®Google Scholar
• Fernandez-Patron C., Radomski M. W., Davidge S. T. Vascular matrix metalloproteinase-2 cleaves big endothelin-1 yielding a novel vasoconstrictor. Circulation Research 1999; 85: 906–911
   PubMed Web of Science ®Google Scholar
• Ferri C., Bellini C., Desideri G., Di Francesco L., Baldoncini R., Santucci A., et al. Plasma endothelin-1 levels in obese hypertensive and normotensive men. Diabetes 1995; 44: 431–436
   PubMed Web of Science ®Google Scholar
• Ferri C., Bellini C., Desideri G., Giuliani E., De Siati L., Cicogna S., et al. Clustering of endothelial markers of vascular damage in human salt-sensitive hypertension: Influence of dietary sodium load and depletion. Hypertension 1998; 32: 862–868
   PubMed Web of Science ®Google Scholar
• Franklin S. S., Khan S. A., Wong N. D., Larson M. G., Levy D. Is pulse pressure useful in predicting risk for coronary heart Disease? The Framingham heart study. Circulation 1999; 100: 354–360
   PubMed Web of Science ®Google Scholar
• Gauderman W. J., Murcray C., Gilliland F., Conti D. V. Testing association between disease and multiple SNPs in a candidate gene. Genetic Epidemiology 2007; 31: 383–395
   PubMed Web of Science ®Google Scholar
• Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007b; 447: 661–678
   PubMed Web of Science ®Google Scholar
• Gerli R., Sherer Y., Vaudo G., Schillaci G., Gilburd B., Giordano A., et al. Early atherosclerosis in rheumatoid arthritis: effects of smoking on thickness of the carotid artery intima media. Annals of the New York Academy of Sciences 2005; 1051: 281–290
   PubMed Web of Science ®Google Scholar
• Goodson N. Coronary Artery disease in rheumatoid arthritis. Current Opinion in Rheumatology 2002; 14: 115–120
   PubMed Web of Science ®Google Scholar
• He F. J., MacGregor G. A. Effect of longer-term modest salt reduction on blood pressure. Cochrane Databas System Reviews 2004, CD004937
   Google Scholar
• Inoue A., Yanagisawa M., Kimura S., Kasuya Y., Miyauchi T., Goto K., et al. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proceedings of the National Academy of Sciences of the United States of American 1989; 86: 2863–2867
   PubMed Web of Science ®Google Scholar
• Ishiguro N., Ito T., Miyazaki K., Iwata H. Matrix metalloproteinases, tissue inhibitors of metalloproteinases, and glycosaminoglycans in synovial fluid from patients with rheumatoid arthritis. Journal of Rheumatology 1999; 26: 34–40
   PubMed Web of Science ®Google Scholar
• Kahaleh M. B., Fan P. S. Effect of cytokines on the production of endothelin by endothelial cells. Clinical and Experimental Rheumatology 1997; 15: 163–167
   PubMed Web of Science ®Google Scholar
• Katz A., Nambi S. S., Mather K., Baron A. D., Follmann D. A., Sullivan G., et al. Quantitative insulin sensitivity check index: A simple, accurate method for assessing insulin sensitivity in humans. Journal of Clinical Endocrinology and Metabolism 2000; 85: 2402–2410
   PubMed Web of Science ®Google Scholar
• Kiowski W., Luscher T. F., Linder L., Buhler F. R. Endothelin-1-induced vasoconstriction in humans. Reversal by calcium channel blockade but not by nitrovasodilators or endothelium-derived relaxing factor. Circulation 1991; 83: 469–475
   PubMed Web of Science ®Google Scholar
• Kirwan J. R., Reeback J. S. Stanford Health Assessment Questionnaire modified to assess disability in British patients with rheumatoid arthritis. British Journal of Rheumatology 1986; 25: 206–209
   PubMedGoogle Scholar
• Kitas G. D., Erb N. Tackling ischaemic heart disease in rheumatoid arthritis. Rheumatology 2003; 42: 607–613
   PubMed Web of Science ®Google Scholar
• Kohno M., Yasunari K., Murakawa K., Yokokawa K., Horio T., Fukui T., et al. Plasma immunoreactive endothelin in essential hypertension. American Journal of Medicine 1990; 88: 614–618
   PubMed Web of Science ®Google Scholar
• Kuryliszyn-Moskal A., Klimiuk P. A., Sierakowski S., Ciolkiewicz M. A study on vascular endothelial growth factor and endothelin-1 in patients with extra-articular involvement of rheumatoid arthritis. Clinical Rheumatology 2006; 25: 314–319
   PubMed Web of Science ®Google Scholar
• La Montagna G., Cacciapuoti F., Buono R., Manzella D., Mennillo G. A., Arciello A., et al. Insulin resistance is an independent risk factor for atherosclerosis in rheumatoid arthritis. Diabetes and Vascular Disease Research 2007; 4: 130–135
   PubMedGoogle Scholar
• Letizia C., Cerci S., De Toma G., D'Ambrosio C., De Ciocchis A., Coassin S., et al. High plasma endothelin-1 levels in hypertensive patients with low-renin essential hypertension. Journal of Human Hypertension 1997; 11: 447–451
   PubMed Web of Science ®Google Scholar
• Levin E. R. Endothelins. New England Journal of Medicine 1995; 333: 356–363
   PubMed Web of Science ®Google Scholar
• Levy D., Larson M. G., Benjamin E. J., Newton-Cheh C., Wang T. J., Hwang S. J., et al. Framingham Heart Study 100K Project: Genome-wide associations for blood pressure and arterial stiffness. BMC Medical Genetics 2007; 8(Suppl 1)S3
   PubMedGoogle Scholar
• LightCycler 2.0 System. 2007c, https://www.roche-applied-science.com/sis/rtpcr/lightcycler/index.jsp
   Google Scholar
• Matsumura Y., Hashimoto N., Taira S., Kuro T., Kitano R., Ohkita M., et al. Different contributions of endothelin-A and endothelin-B receptors in the pathogenesis of deoxycorticosterone acetate-salt-induced hypertension in rats. Hypertension 1999; 33: 759–765
   PubMed Web of Science ®Google Scholar
• Matthews D. R., Hosker J. P., Rudenski A. S., Naylor B. A., Treacher D. F., Turner R. C. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412–419
   PubMed Web of Science ®Google Scholar
• Murlas C. G., Sharma A. C., Gulati A., Najmabadi F. Interleukin-1 beta increases airway epithelial cell mitogenesis partly by stimulating endothelin-1 production. Lung 1997; 175: 117–126
   PubMed Web of Science ®Google Scholar
• National Collaborating Centre for Chronic Conditions. Hypertension: Management of Hypertension in Adults in Primary Care: Partial Update. Royal College of Physicians, London 2006
   Google Scholar
• Pache M., Schwarz H. A., Kaiser H. J., Wuest P., Kloti M., Dubler B., et al. Elevated plasma endothelin-1 levels and vascular dysregulation in patients with rheumatoid arthritis. Medical Science Monitor 2002; 8: CR616–CR619
   PubMedGoogle Scholar
• Panoulas V. F., Douglas K. M., Milionis H. J., Stavropoulos-Kalinglou A., Nightingale P., Kita M. D., et al. Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis. Rheumatology 2007; 46: 1477–1482
   PubMed Web of Science ®Google Scholar
• Panoulas V. F., Metsios G. S., Pace A. V., John H., Treharne G. J., Banks M. J., et al. Hypertension in rheumatoid arthritis. Rheumatology May 29, 2008, [Epub ahead of print], doi: 10.1093/rhewmatology/ken159
   Google Scholar
• Parrinello G., Scaglione R., Pinto A., Corrao S., Cecala M., Di Silvestre G., et al. Central obesity and hypertension: the role of plasma endothelin. American Journal of Hypertension 1996; 9: 1186–1191
   PubMed Web of Science ®Google Scholar
• Prevoo M. L., van't Hof M. A., Kuper H. H., van Leeuwen M. A., van de Putte L. B., van Riel P. L. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis and Rheumatism 1995; 38: 44–48
   PubMed Web of Science ®Google Scholar
• Raza K., Breese M., Nightingale P., Kumar K., Potter T., Carruthers D. M., et al. Predictive value of antibodies to cyclic citrullinated peptide in patients with very early inflammatory arthritis. Journal of Rheumatology 2005; 32: 231–238
   PubMed Web of Science ®Google Scholar
• Ridker P. M., Danielson E., Rifai N., Glynn R. J. Valsartan, blood pressure reduction, and C-reactive protein: primary report of the Val-MARC trial. Hypertension 2006; 48: 73–79
   PubMed Web of Science ®Google Scholar
• Rocchini A. P. Obesity hypertension, salt sensitivity and insulin resistance. Nutrition, Metabolism, and Cardiovascular Disease 2000; 10: 287–294
   PubMed Web of Science ®Google Scholar
• Roman M. J., Moeller E., Davis A., Paget S. A., Crow M. K., Lockshin M. D., et al. Preclinical carotid atherosclerosis in patients with rheumatoid arthritis. Annals of Internal Medcine 2006; 144: 249–256
   PubMed Web of Science ®Google Scholar
• Sarafidis P. A., Bakris G. L. Review: Insulin and endothelin: an interplay contributing to hypertension development?. Journal of Clinical Endocrinology and Metabolism 2007; 92: 379–385
   PubMed Web of Science ®Google Scholar
• Schiffrin E. L. Role of endothelin-1 in hypertension and vascular disease. American Journal of Hypertension 2001; 14: 83S–89S
   PubMed Web of Science ®Google Scholar
• Schiffrin E. L., Thibault G. Plasma endothelin in human essential hypertension. American Journal of Hypertension 1991; 4: 303–308
   PubMed Web of Science ®Google Scholar
• Sessa W. C., Kaw S., Hecker M., Vane J. R. The biosynthesis of endothelin-1 by human polymorphonuclear leukocytes. Biochemical and Biophysical Research Communications 1991; 174: 613–618
   PubMed Web of Science ®Google Scholar
• Singh G., Miller J. D., Huse D. M., Pettitt D., D'Agostino R. B., Russell M. W. Consequences of increased systolic blood pressure in patients with osteoarthritis and rheumatoid arthritis. Journal of Rheumatology 2003; 30: 714–719
   PubMed Web of Science ®Google Scholar
• Stavropoulos-Kalinoglou A., Metsios G. S., Koutedakis Y., Nevill A. M., Douglas K. M., Jamurtas A., et al. Redefining overweight and obesity in rheumatoid arthritis patients. Annals of Rheumatic Diseases 2007; 66: 1316–1321
   PubMed Web of Science ®Google Scholar
• Stephens M., Donnelly P. A comparison of bayesian methods for haplotype reconstruction from population genotype data. American Journal of Human Genetics 2003; 73: 1162–1169
   PubMed Web of Science ®Google Scholar
• Tanira M. O., Al Balushi K. A. Genetic variations related to hypertension: A review. Journal of Human Hypertension 2005; 19: 7–19
   PubMed Web of Science ®Google Scholar
• Teder P., Noble P. W. A cytokine reborn? Endothelin-1 in pulmonary inflammation and fibrosis. American Jounal of Respiration Cell and Molecular Biology 2000; 23: 7–10
   PubMed Web of Science ®Google Scholar
• Tiret L., Poirier O., Hallet V., McDonagh T. A., Morrison C., McMurray J. J., et al. The Lys198Asn polymorphism in the endothelin-1 gene is associated with blood pressure in overweight people. Hypertension 1999; 33: 1169–1174
   PubMed Web of Science ®Google Scholar
• Vaccarino V., Berger A. K., Abramson J., Black H. R., Setaro J. F., Davey J. A., et al. Pulse pressure and risk of cardiovascular events in the systolic hypertension in the elderly program. American Journal of Cardiology 2001; 88: 980–986
   PubMed Web of Science ®Google Scholar
• Vane J. R., Anggard E. E., Botting R. M. Regulatory functions of the vascular endothelium. New England Journal of Medicine 1990; 323: 27–36
   PubMed Web of Science ®Google Scholar
• Vervoordeldonk M. J., Tak P. P. Cytokines in rheumatoid arthritis. Current Rheumatology Reports 2002; 4: 208–217
   PubMedGoogle Scholar
• Wallberg-Jonsson S., Johansson H., Ohman M. L., Rantapaa-Dahlqvist S. Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset. Journal of Rheumatology 1999; 26: 2562–2571
   PubMed Web of Science ®Google Scholar
• Williams B., Poulter N. R., Brown M. J., Davis M., McInnes G. T., Potter J. F., et al. Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society 2004-BHS IV. Journal of Human Hypertension 2004a; 18: 139–185
   PubMed Web of Science ®Google Scholar
• Williams B., Poulter N. R., Brown M. J., Davis M., McInnes G. T., Potter J. F., et al. British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary. British Journal of Medicine 2004b; 328: 634–640
   PubMed Web of Science ®Google Scholar
• Wiltshire S., Powell B. L., Jennens M., McCaskie P. A., Carter K. W., Palmer L. J., et al. Investigating the association between K198N coding polymorphism in EDN1 and hypertension, lipoprotein levels, the metabolic syndrome and cardiovascular disease. Human Genetics 2008; 123: 307–313
   PubMed Web of Science ®Google Scholar
• Wolfe F., Freundlich B., Straus W. L. Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis. Journal of Rheumatology 2003; 30: 36–40
   PubMed Web of Science ®Google Scholar
• Woods M., Mitchell J. A., Wood E. G., Barker S., Walcot N. R., Rees G. M., et al. Endothelin-1 is induced by cytokines in human vascular smooth muscle cells: evidence for intracellular endothelin-converting enzyme. Molecular Pharmacology 1999; 55: 902–909
   PubMed Web of Science ®Google Scholar
• Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411–415
   PubMed Web of Science ®Google Scholar
• Yoshida H., Imafuku Y., Ohhara M., Miyata M., Kasukawa R., Ohsumi K., et al. Endothelin-1 production by human synoviocytes. Annals of Clinical Biochemistry 1998; 35: 290–294, (Pt 2)
   PubMed Web of Science ®Google Scholar
• Zhao R. Z., Chen X., Yao Q., Chen C. TNF-alpha induces interleukin-8 and endothelin-1 expression in human endothelial cells with different redox pathways. Biochemical and Biophysical Research Communications 2005; 327: 985–992
   PubMed Web of Science ®Google Scholar